Matinas生物制藥

MTNB
1.29014.57% ( -0.220 )
已收盤: 11月2日 16:00:00 (美東)

全部股東

股東類型

  • 公眾及其他75.32%
  • 個人與內幕人士11.96%
  • 私人企業10.14%
  • 機構投資者2.58%

主要股東

主要股東 最新
股東
Hezbay Holdings Llc
8.89%8.71 萬4.93%+7.02 萬13/07/2026
Adam SternFormer Director
8.16%7.99 萬5.38%+6.81 萬
David Lazar
3.71%3.63 萬4.80%+016/03/2026
111 Equity Group LLC
1.25%1.22 萬1.62%+013/02/2025
Renaissance Technologies LLC
0.48%4,736.000.04%+2,832.0030/06/2026
Vanguard Capital Management, LLC
0.39%3,828.000.52%-64.0030/06/2026
BlackRock, Inc.
0.34%3,350.000.43%+40.0030/06/2026
Geode Capital Management, LLC
0.33%3,275.000.68%-1,069.0030/06/2026
Holos Integrated Wealth, LLC
0.22%2,165.000.29%+030/09/2026
AKS Family Foundation
0.18%1,767.000.23%+0
Stern Aegis Ventures, Llc Defined Benefit Plan
0.15%1,423.000.19%+013/02/2025
Susquehanna International Group, LLP
0.11%1,072.000.11%+117.0030/06/2026
Citadel Advisors LLC
0.11%1,031.000.70%-2,415.0030/06/2026
State Street Investment Management
0.10%1,021.000.13%+030/06/2026
Sargent Investment Group, LLC
0.09%848.000.11%+030/06/2026
Jerome JabbourCo-Founder, Chairman, CEO, President & Interim CFO
0.06%614.000.08%+016/03/2026
Pavilion Capital Partners LLC
0.04%400.000.05%+0
Tower Research Capital Europe Limited
0.02%190.000.03%+030/06/2026
Keith KucinskiFormer Chief Financial Officer
0.01%126.000.02%+016/03/2026
Robert Eide
0.01%100.000.01%+0